CHRN
TECHNOLOGYChronoScale Corporation
What's Moving CHRN Today?
No stock-specific AI insight has been generated for CHRN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$24.29
Fundamentals
Trading
CHRN News
3 articles- Adeia Picks a Fight, and Investors Pick the ExitTrefis·Jul 3, 2026
- ChronoScale (CHRN) Stock Valuation After Sharp 1 Year Surge And Rich P/S MultipleYahoo Finance·Jun 13, 2026
- ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure StrategyYahoo Finance·Jun 4, 2026
All 3 articles loaded
Price Data
52-Week Range
$24.29
Fundamentals
Trading
About ChronoScale Corporation
ChronoScale Corporation (Ticker: CHRN) is a cutting-edge biotechnology company dedicated to transforming healthcare by developing and commercializing innovative therapeutics that address unmet medical needs. The firm boasts a robust pipeline supported by strategic collaborations and is committed to leveraging advanced technologies to enhance patient care outcomes. Through its unwavering focus on scientific excellence and a dynamic approach to the evolving healthcare landscape, CHRN is strategically positioned to emerge as a prominent leader in the biotechnology sector, poised to capitalize on new opportunities within the industry.